A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma
Clinical trial NCT00495612 · COMPLETED
Trial details
- NCT number
- NCT00495612
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-06-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.